Novartis India's Stock Performance Declines, 'Hold' Call by MarketsMOJO

Novartis India, a leading pharmaceutical company in India, has been facing a downward trend in its stock performance. On October 7th, 2024, the company's stock lost -8.98%, underperforming the sector by -5.24%. This has led to a 'Hold' call by MarketsMOJO.

The stock has been on a consecutive fall for the last 6 days, with a decline of -13.47% in this period. On the same day, the stock touched an intraday low of Rs 989.35, a decrease of -7.52%. This is a cause for concern for investors.

Novartis India's stock is currently trading below its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages. This indicates a negative trend in the company's stock performance.

In comparison to the overall market performance, Novartis India's stock has underperformed. On the day of the stock's decline, it performed -7.73% while the Sensex only saw a decrease of -0.25%. In the past month, the stock has also performed poorly, with a decline of -9.46% compared to the Sensex's increase of 0.37%.

Investors should keep a close eye on Novartis India's stock performance and consider the 'Hold' call by MarketsMOJO before making any investment decisions.